Advertisement

Topics

Senior notes offering pulls in nearly $1.7B for Baxter

08:24 EDT 16 May 2019 | SmartBrief

An offering of 0.4% senior notes due 2024 and 1.3% senior notes due 2029 has been completed by Baxter, generating around $1.6 -More

Original Article: Senior notes offering pulls in nearly $1.7B for Baxter

NEXT ARTICLE

More From BioPortfolio on "Senior notes offering pulls in nearly $1.7B for Baxter"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...